A New Level of Biotech.
Intrexon Corporation employs modular DNA control systems to enhance capabilities, improve safety and lower cost in therapeutics, human protein production, industrial enzymes and agbio.
The company's advanced transgene engineering platform enables a new level of biotech - combining
breakthroughs in modular DNA control systems with corresponding advancements in transgene design,
assembly and optimization. The company is currently using these advanced capabilities to solve
foremost challenges across the life sciences spectrum, including novel therapies for solid tumor cancers
and super-secretor cell lines for improved production of human therapeutic proteins.
Intrexon is applying its modular DNA control systems and combinatorial transgene optimization
capabilities to substantially improve global health and economic well-being.